HH
HDO Health develops the Journiquet™, a novel Class II medical device designed to stop traumatic junctional bleeding. This pre-assembled tourniquet allows for rapid, intuitive application using only gross motor movements, even in high-stress environments. The device provides consistent hemorrhage control during patient transport and is designed to be cost-effective for widespread adoption.
Updated 4 months ago
Funding
$1K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- HDO Health develops the Journiquet™, a novel Class II medical device designed to stop traumatic junctional bleeding. This pre-assembled tourniquet allows for rapid, intuitive application using only gross motor movements, even in high-stress environments. The device provides consistent hemorrhage control during patient transport and is designed to be cost-effective for widespread adoption.